カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の喘息治療薬市場2023-2030：薬剤クラス別（抗炎症薬、併用療法）、製品別（吸入器、ネブライザー）、投与経路別、地域別

【英語タイトル】Asthma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti-inflammatory, Combination Therapy), By Product (Inhalers, Nebulizers), By Route Of Administration, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV046）・商品コード：GRV23NOV046
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：126
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

喘息治療薬市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の喘息治療薬市場規模は2023年から2030年にかけて年平均成長率4.3%で拡大し、2030年には332億米ドルに達すると予測されています。喘息の有病率の増加と、重症の喘息を治療するための長期的な治療オプションとしての生物製剤の採用は、この市場に有利な成長機会を提供すると期待されています。World Allergy Journalが発表した統計によると、2014年5月に喘息を患った患者は約3億人に上り、不健康な食生活や座りがちなライフスタイルに傾倒する人が多いことから、その数は急増すると予想されています。

また、予測期間中にシングレア、アドエアなどの主要なブランド薬の特許が失効したことで、ジェネリック医薬品の競争が激化し、今後数年間は喘息治療薬市場の成長にマイナスの影響を与えるでしょう。逆に、生物学的製剤の導入は、喘息治療薬セグメントの市場シェア拡大につながっており、予測期間中も続くと予想されます。

重度の喘息治療のための従来の投薬処方パターンとは対照的に、個別化医療アプローチに対する需要の高まりは、将来の喘息治療薬市場の出現を支援すると予想されます。さらに、センサー技術や内蔵無線通信システムを備えた加圧式定量吸入器やスマート吸入器などの技術的に高度な製品の開発は、今後7年間の喘息治療薬市場の成長をさらに促進すると予想されます。

喘息治療薬市場レポートハイライト

- 抗炎症薬クラスは、重度の喘息状態をターゲットとする手頃な価格の革新的な生物製剤の導入により、予測期間中にCAGR 3.4%の好利な急成長を示す見込みです。さらに、生物学的製剤やモノクローナル抗体によってもたらされる利点に関する認知度の向上により、今後数年間で市場の拡大が見込まれます。

- ドライパウダー吸入器（DPI）は、他の吸入器よりも臨床効率が高いため、これらのデバイスの採用が増加しているため、最も急成長しているセグメントになると予想されます。ドライパウダー吸入器（DPI）は、他の吸入器よりも臨床効率が高いため、採用が増加しています。このような利点が採用率を急上昇させ、市場浸透率の上昇に寄与しています。

- 喘息治療薬として吸入合剤のような代替治療法を選択する個人数の増加は、この市場に将来の成長機会をもたらすと予想されます。吸入器市場は予測期間中2.0%以上のCAGRで成長する見込みです。

- 喘息治療薬市場で事業を展開する主要企業には、AstraZeneca Plc、Philips Healthcare、Teva Pharmaceutical Industries Ltd.、GlaxoSmithKline Plc、Sanofi-Aventis SA、CareFusion Corporation、Sunovion Pharmaceuticals, Inc.、Boehringer Ingelheim GmbH、Roche Diagnostics、Merck&Co, Inc.などがあります。

- 市場リーダーは、競争上の優位性を獲得するため、技術的に高度な機器や新規の改良型生物製剤の導入に注力しています。喘息治療薬の分野では、開発段階にある新規分子が100近くあり、メーカー各社が個別化医療の開発に注力しているため、パイプラインが非常に充実しています。前述の要因は総体的に、近い将来の業界の成長を強化するものです。

- 例えば、Teva Pharmaceutical Industries Ltd.のCinquil、RocheのLebrikizumab（フェーズIII）、AB ScienceのMastinib（フェーズII/III）、GlaxoSmithKline PlcのBosatria（フェーズIII）などの医薬品分子は、臨床研究試験中の開発段階にあります。予測期間中に商業利用が可能になれば、この分野に弾みがつくと期待されています。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の喘息治療薬市場変数・傾向・範囲
第4章 世界の喘息治療薬市場：薬剤クラス別予測・傾向分析
第5章 世界の喘息治療薬市場：製品別予測・傾向分析
第6章 世界の喘息治療薬市場：投与経路別予測・傾向分析
第7章 世界の喘息治療薬市場：地域別予測・傾向分析
第8章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Drug Class
1.1.2. Product
1.1.3. Route of Administration
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Drug class outlook
2.2.2. Product outlook
2.2.3. Route of administration outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Asthma Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing incidence of asthma
3.3.1.2. Introduction of novel biologics
3.3.1.3. Rising government initiatives
3.3.2. Market restraint analysis
3.4. Asthma Therapeutics Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Asthma Therapeutics Market: Drug Class Estimates & Trend Analysis
4.1. Asthma Therapeutics Market: Key Takeaways
4.2. Asthma Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Anti-inflammatory
4.3.1. Anti-inflammatory market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Bronchodilators
4.4.1. Bronchodilators market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Combination Therapy
4.5.1. Combination therapy market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Asthma Therapeutics Market: Product Estimates & Trend Analysis
5.1. Asthma Therapeutics Market: Key Takeaways
5.2. Asthma Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Inhalers
5.3.1. Inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.2. Dry powder inhalers
5.3.2.1. Dry powder inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.3. Metered-dose inhalers
5.3.3.1. Metered-dose inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.4. Soft mist inhalers
5.3.4.1. Soft mist inhalers market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Nebulizers
5.4.1. Nebulizers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Asthma Therapeutics Market: Route of Administration Estimates & Trend Analysis
6.1. Asthma Therapeutics Market: Key Takeaways
6.2. Asthma Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Oral
6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Inhaled
6.4.1. Inhaled market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Asthma Therapeutics Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Asthma Therapeutics Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Teva Pharmaceutical Industries Ltd.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. GSK plc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Merck& Co., Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. F. Hoffmann-La Roche Ltd
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. AstraZeneca
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Boehringer Ingelheim International GmbH.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Sanofi
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Koninklijke Philips N.V.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. BD
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Sunovion Pharmaceuticals, Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 3 North America asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 4 North America asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 5 North America asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 7 U.S. asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 9 Canada asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 10 Canada asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 11 Canada asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 12 Europe asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 13 Europe asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 14 Europe asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 15 Europe asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 16 Germany asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 17 Germany asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 18 Germany asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 19 UK asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 20 UK asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 21 UK asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 22 France asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 23 France asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 24 France asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 25 Italy asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 26 Italy asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 27 Italy asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 28 Spain asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 29 Spain asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 30 Spain asthma therapeutics market, by route of administration, (USD Million) 2018 - 2030
Table 31 Denmark asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 32 Denmark asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 33 Denmark asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 34 Sweden asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 35 Sweden asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 36 Sweden asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 37 Norway asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 38 Norway asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 39 Norway asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 40 Asia Pacific asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 41 Asia Pacific asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 43 Asia Pacific asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 44 Japan asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 45 Japan asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 46 Japan asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 47 China asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 48 China asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 49 China asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 50 India asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 51 India asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 52 India asthma therapeutics market, by route of administration, (USD Million) 2018 - 2030
Table 53 Australia asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 54 Australia asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 55 Australia asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 56 Thailand asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 57 Thailand asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 58 Thailand asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 59 South Korea asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 60 South Korea asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 62 Latin America asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 63 Latin America asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 65 Latin America asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 67 Brazil asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 68 Brazil asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 69 Mexico asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 70 Mexico asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 71 Mexico asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 72 Argentina asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 73 Argentina asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa asthma therapeutics market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 80 South Africa asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 85 UAE asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 86 UAE asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 87 UAE asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)
Table 88 Kuwait asthma therapeutics market, by drug class, 2018 - 2030 (USD Million)
Table 89 Kuwait asthma therapeutics market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait asthma therapeutics market, by route of administration, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Asthma therapeutics: Market outlook
Fig. 9 Asthma therapeutics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Asthma therapeutics market driver impact
Fig. 15 Asthma therapeutics market restraint impact
Fig. 16 Asthma therapeutics market strategic initiatives analysis
Fig. 17 Asthma therapeutics market: Drug class movement analysis
Fig. 18 Asthma therapeutics market: Drug class outlook and key takeaways
Fig. 19 Anti-inflammatory market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Bronchodilators market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Combination therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Asthma therapeutics market: Product movement analysis
Fig. 23 Asthma therapeutics market: Product outlook and key takeaways
Fig. 24 Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Dry powder inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Metered-dose inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Soft mist inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Asthma therapeutics market: Route of administration movement analysis
Fig. 30 Asthma therapeutics market: Route of administration outlook and key takeaways
Fig. 31 Oral market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Inhaled market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Global asthma therapeutics market: Regional movement analysis
Fig. 35 Global asthma therapeutics market: Regional outlook and key takeaways
Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

★調査レポート[世界の喘息治療薬市場2023-2030：薬剤クラス別（抗炎症薬、併用療法）、製品別（吸入器、ネブライザー）、投与経路別、地域別] (コード：GRV23NOV046)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の喘息治療薬市場2023-2030：薬剤クラス別（抗炎症薬、併用療法）、製品別（吸入器、ネブライザー）、投与経路別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗感染症薬市場2023-2030：種類/薬剤クラス別（抗ウイルス薬、抗真菌薬）、投与経路別、流通チャネル別、地域別
  • 世界の降圧薬市場2024-2030：薬剤クラス別（利尿薬、ACE阻害薬）、種類別（一次、二次）、投与経路別、流通チャネル別、地域別
  • 世界のピーナッツアレルギー治療薬市場2024-2030：薬剤クラス別（抗ヒスタミン薬、エピネフリン）、投与経路別、流通チャネル別、地域別
  • 世界の炎症性腸疾患（IBD）治療市場2023-2030：種類別（クローン病、潰瘍性大腸炎）、薬剤クラス別、投与経路別、流通チャネル別、地域別
  • 世界のアスペルギルス症治療市場2023-2030：タイプ別（アレルギー性、慢性、侵襲性）、薬剤クラス別（抗真菌薬）、投与経路別、流通チャネル別、地域別
  • 世界の大腸がん治療薬市場2023-2030：薬剤クラス別（化学療法、免疫療法）、地域別（北米、アジア太平洋、中南米、ヨーロッパ）
  • 世界の遺伝性血管性浮腫治療薬市場2023-2030：薬剤クラス別（C1-エステラーゼ阻害剤、ブラジキニンB2受容体拮抗剤、カリクレイン阻害剤、その他）、治療別（予防、オンデマンド療法）、投与経路別（静脈内、皮下、経口）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆